je.st
news
Tag: risk
Bureau Seeking Input on Risk Category III & IV Buildings
2015-12-08 17:50:56| PortlandOnline
To facilitate gathering this input BDS is hosting a workshop on December 9, 2015 at 1900 SW 4th Avenue, room 2500A from 8:00 am to noon.
Exxon Mobil - Good Income Investment With Short-Term Downside Risk
2015-12-07 22:28:28| Chemicals - Topix.net
There is potential for more share price declines due to the fact that the oil price is near its 52 week low, whereas Exxon Mobil trades well above its lows. Exxon Mobil is the biggest publicly traded oil and gas company and a favorite among income and dividend growth investors.
Tags: good
risk
investment
income
Exxon Mobil - Good Income Investment With Short-Term Downside Risk
2015-12-07 22:17:32| Oil & Gas - Topix.net
There is potential for more share price declines due to the fact that the oil price is near its 52 week low, whereas Exxon Mobil trades well above its lows. Exxon Mobil is the biggest publicly traded oil and gas company and a favorite among income and dividend growth investors.
Tags: good
risk
investment
income
Big business: are deforestation goals at risk failing?
2015-12-07 15:19:00| Climate Ark Climate Change & Global Warming Newsfeed
Guardian: The Paris climate talks have opened with a promise to the world: to secure a historic agreement between nations to bring the runaway train of global warming to a halt. The worlds forests play a key role in fulfilling this promise. When we keep forests standing, we have an invaluable asset in our fight against climate change. As writer Sam Knight has already highlighted in the Guardian: There are three trillion trees on Earth and they are perfectly made to take carbon dioxide out of the atmosphere....
J&J leukemia drug cuts death risk vs. chemo in new patients: study
2015-12-07 03:47:40| Food - Topix.net
Johnson & Johnson's and AbbVie's cancer drug Imbruvica significantly reduced the risk of death and disease progression compared with chemotherapy in previously untreated patients with a type of leukemia in a late stage study, paving the way for an expanded approval of the medicine. In the trial of 269 patients aged 65 and older with chronic lymphocytic leukemia , Imbruvica decreased risk of death by a statistically significant 85 percent compared with the chemotherapy chlorambucil, researchers reported on Sunday.
Sites : [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] next »